Anita Thapar, FRCPsych, PhD, CBE, FMedSci
Genetics and phenotypical associations
Anita is a clinical academic child and adolescent psychiatrist. She heads the academic Child & Adolescent Psychiatry section at the Division of Psychological Medicine and Clinical Neurosciences, Cardiff University and also directs the developmental disorders group within the MRC Centre for Neuropsychiatric Genetics and Genomics.
Her research focuses on the origins, development and complications of child neurodevelopmental disorders focusing mainly on ADHD but also on adolescent depression. Currently funded research investigations focus on the natural history of ADHD and Autism into adult life, the contribution of genetic and early life exposures to ADHD and ASD trajectories and investigations on youth depression including the recently funded £10million Wolfson Centre for Youth Mental Health in Wales.
Anne Amalie Elgaard Thorup
The Danish High Risk and Resilience Studies: VIA 7 - VIA 15
Professor Thorup is a specialist in child and adolescent psychiatry, with a focus on prevention and early intervention.
Since 2012, Professor Thorup has led the ‘The Danish High Risk and Resilience Study- VIA 7’ – a cohort study of 522 7 year old children born of parents diagnosed with either schizophrenia, bipolar disorder or neither of these two mental disorders. Having a first-degree relative with schizophrenia or bipolar disorder is the strongest known risk factor for developing these disorders. The Via cohort is the largest familial high risk study in the world and is being followed up over time, first time assessed at age 7, then at age 11 (VIA 11-study) and age 15 (VIA 15 study, ongoing) and VIA 19 is in the planning. Results have consistently shown that children born with a predisposition for severe mental illness show early signs of vulnerability and deviant development in many aspects. There is a potential for improving preventive strategies and support for these families, both in order to increase recovery in the parents and reduce stigma, to support family functioning and to prevent illness development in the children’s future. Further, a randomized, multidisciplinary intervention study, The Via Family Pilot study, providing a specialized and cross-sectional intervention for children and parents in high risk families, has been conducted and a large scale study is being planned along with register studies in the same field.
Christoph Corell, professor
Pharmacologic Treatment and Research in Youth with Severe Mental Illness in Europe: Current Status and Next Steps
Christoph U. Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York City. Since 1997, he has been working and conducting research in New York, USA, and since 2017 he is also working in Germany again. Professor Correll focuses on the identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and the interface between physical health and mental health.
He has authored or co-authored over 800 journal articles that have been cited more than 58.000 times and received over 40 research awards for his work. In October 2022, his H-index was 126 in Google Scholar and 96 in Web of Science. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry” (https://hcr.clarivate.com). Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, i.e., for 15 topics as “Expert” (among the top 1% cited scientists), and 24 topics as “World Expert” (among the top 0.1% cited scientists)
Henning Tiemeier, professor
Birth cohorts and child psychiatric epidemiology: some milestones and many challenges
Henning Tiemeier, MA, MD, PhD, is Professor of Social and Behavioral Science and the Sumner and Esther Feldberg Chair of Maternal and Child Health at the Harvard T.H. Chan School of Public Health. Dr. Tiemeier received both his medical and sociological degree from the University of Bonn, Germany, and his PhD from the Erasmus University in Rotterdam, Netherlands. Since 2018, he leads the Maternal and Child Center of Excellence at Harvard Chan. As one of just 13 HRSA-funded Centers of Excellence in Maternal and Child Health in the United States, the center trains future leaders in the field. Dr. Tiemeier have worked broadly in pediatric epidemiology for more than 20 years with an emphasis on child developmental research. At Harvard his research focusses on high-risk children, such as preterm children and homeless families. Together with colleagues and non-governmental agencies he has begun a cohort of women in Boston shelters and their children.
Dr. Tiemeier has published extensively on the etiology of child developmental problems with a particular focus on prenatal exposures. His other research interests include social and family environmental determinants of brain development, parental feeding and child eating behavior, and psychometric studies of child development, among others. He is a principal investigator of the Generation R Study, a large pre-birth cohort in Rotterdam, that enrolled nearly 10,000 mothers and their children. Ongoing research projects and interests focus on genetic and early life exposures; as his previous work showed that this shapes the vulnerability to neurodevelopmental problems. His ongoing studies include investigate how parenting and other environmental risk factors relate to brain development as assessed by braining imaging.
Ruth Feldman, professor
Attachment and Resilience
Ruth Feldman, PhD is the Simms-Mann professor and director of the Center of Developmental, Social, and Relationship Neuroscience at Reichman University, Israel, directs the Irving B. Harris public clinic for young children and their families, and is an adjunct professor at Yale University Child Study Center. Her empirical research and theoretical models focus on the neurobiology of human attachments, processes of biobehavioral synchrony, and the biology of resilience. Her studies on the role of oxytocin, the parental brain, inter-brain synchrony, and the neuroscience of empathy have been instrumental in describing the biological basis of human social collaboration and widely published in the media. In several birth-to-adulthood studies she mapped the long-term effects of premature birth, maternal depression, and chronic trauma on brain and behavior and described the long-term effects of touch-based interventions on the adult brain. Her dialogue-enhancing intervention for Israeli and Palestinian youth is the first to show long-term effects on brain and behavior in the context of intractable inter-group conflict. Dr. Feldman was named a highly-cited researcher (2018), World Expert in parenting research (2019), and is the recipient of the 2018 Graven's Award for research on high-risk infants, the 2022 award of the Society of Reproductive and Infant Psychology, and the 2020 EMET prize, Israel's highest prize in arts and sciences.
Tamsin Ford, professor
Mental Health interventions in schools and preventative measures in general
Tamsin Ford is a Professor of Child and Adolescent Psychiatry at the University of Cambridge. Her academic work focuses on the effectiveness of interventions and the efficiency of services in relation to the mental health of children and young people, with a particular focus on the interface between the education and health systems. She completed her PhD at the Institute of Psychiatry, and moved to Exeter in 2007, where she set up the Child Mental Health Research Group. She moved to Cambridge in 2019 where she leads the ChARM (Child and Adolescent Resilience and Mental health) Research Group. She is also Vice Chair of the Association of Child and Adolescent Mental Health and consults to Place2Be on evidence-based approaches to their work in supporting the mental health of children in schools.
State of the art speakers
Andrea Danese, MD Phd, Professor of Child & Adolescent Psychiatry
Childhood adversity and psychopathology: bridging from population science to clinical practice
Andrea Danese, MD, PhD, is Professor of Child & Adolescent Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London as well as Professor Adjunct at the Yale Child Study Center. His team has published highly-cited research on the measurement of childhood trauma, risk factors for trauma exposure, biological mechanisms through which trauma affects later health, mechanisms of resilience, modelling of individualised risk prediction for trauma-related psychopathology, and the epidemiology of child trauma and trauma-related psychopathology. Prof Danese is the recipient of several research awards including the Society for Research in Child Development (SRCD) Early Career Research Contribution Award and the American Academy of Child and Adolescent Psychiatry (AACAP) Senior Researcher Award and has been listed among the Clarivate “Highly Cited” Researcher in Psychiatry and Psychology since 2019.
Professor Danese has established and leads the National & Specialist CAMHS Clinic for Trauma, Anxiety, and Depression at the South London and Maudsley NHS Foundation Trust. The service attracts referrals from across the UK and abroad for second opinion on diagnosis and specialist treatment of difficult-to-treat young people with Post-Traumatic Stress Disorder (PTSD), anxiety disorders, and unipolar depression. The clinic has also advised and worked with the UK government to develop public mental health interventions in the aftermath of emergencies and disasters.
Prof Danese is the Academic Secretary for the Royal College of Psychiatrists’ Faculty of Child & Adolescent Psychiatry. He is also Editor-at-large of the Journal of the American Academy of Child & Adolescent Psychiatry and a member of the Editorial Board for the Journal of Child Psychology and Psychiatry; Brain, Behaviour and Immunity; the Journal of Affective Disorders; and the APA Psychological Trauma.
Website: https://www.kcl.ac.uk/people/andrea-danese
Twitter: @andrea_danese
Argyris Stringaris, professor
Affective Phenomena: Moods, Emotions, Feelings: How are they generated and Maintained?
Professor Argyris Stringaris has been Chair of Child and Adolescent Psychiatry at UCL since January 2022 and is also a Professor of Child and Adolescent Psychiatry at University of Athens. Until December 2021, he was Senior Investigator and Chief of the Section of Clinical and Computational Psychiatry at NIMH/NIH in the USA and before that a Senior Lecturer and a Wellcome Trust Fellow at the Institute of Psychiatry Psychology and Neuroscience, King's College London. He trained in Child and Adolescent Psychiatry at the Maudsley Hospital.
He has two main research aims:
In terms of basic research, my aim is to understand how affective phenomena (variably termed moods, emotions, feelings or affects) are generated and maintained.
In terms of clinical research, I study interventions that reduce the negative impact that affective phenomena, particularly depression, can have on young people and families.
He has received the 2019 Outstanding Mentor Award by NIH, the NIH's Director Award for research in 2020 and was a 2022 Highly Cited Researcher.
Carmen Schroeder, MD, PhD
Sleep disorders and their treatment in children with neurodevelopment disorders
Professor of Child and Adolescent Psychiatry, Faculty of Medicine, Strasbourg University
Head of the Department of Child and Adolescent Psychiatry, Strasbourg University Hospital
Head of the Excellence Centre for Autism and Neurodevelopmental Disorders
President, European Union of Medical Specialists - Child and Adolescent Psychiatry (UEMS-CAP)
European Board Certified Sleep Expert; Secretary General & Scientific Committee, French Society for Sleep Research and Sleep Medicine.
https://www.escap.eu/events/escap-expert-day-25th-june-2021/carmen-schroder-biography
Eva Serlachius, MD, PhD
Internet-delivered cognitive behavioral therapy for pediatric anxiety: Current status and future directions
Eva Serlachius, MD, PhD is a specialist in child and adolescent psychiatry and recently became a professor at Lund University and Region Skåne and Guest professor at Karolinska Institutet (KI). She was, before the transition to Lund, an adjunct professor and research group leader at the department of Clinical Neuroscience, KI. She has been responsible for teaching child and adolescent psychiatry at the medical degree program at KI. Serlachius has also worked with building infrastructure and operations for both research and teaching in child and adolescent psychiatry in Region Stockholm. The main aim of her research is to increase the availability to effective psychological treatments for some of the most common mental health disorders in children and adolescents, specifically anxiety disorders, obsessive-compulsive disorders and depression through the development, evaluation and dissemination of ICBT. In 2020, she received an award for her research on digital innovations https://www.acamh.org/blog/results-of-the-acamh-awardsards-2020/
Johannes Hebebrand
Weight gain crucial for mental and somatic improvement in anorexia nervosa: Alleviation of hypoleptinemia as a central underlying mechanism
Johannes Hebebrand is Head of the Department of Child and Adolescent Psychiatry of the University of Duisburg-Essen. His major research areas include genetics of obesity and eating disorders, assessment of sex, age and height adjusted weight, and the regulation of leptin in AN. His first study to assess serum leptin levels in AN dates back to 1995; subsequent research supported the role of leptin in amenorrhea. He proved that exogenous application of leptin to the best known rat model for AN (anorexia based activity) prevents the development of hyperactivity upon food restriction, leading him to argue that the DSM-IV term ”refusal to maintain body weight at or above minimally normal weight for height/age” is a misnomer. Prior to conducting the first off-label treatment of patients with AN the underlying hypothesis was generated in 2000 and was continuously subjected to fine-tuning. > 600 publications listed in PubMed; Google-Scholar H-Index: 108. Editor-in-Chief of European Child and Adolescent Psychiatry from 2014 to 2022.
Judith Rosmalen, professor
Early experiences related to the body and illness coping with symptoms
Prof. Dr. J. (Judith) G.M. Rosmalen is appointed as a professor in psychosomatic medicine at the departments of Psychiatry and Internal medicine of the University Medical Center Groningen. She studied medical biology (University of Utrecht 1995) and psychology (University of Leiden 1998, cum laude), and obtained her PhD on interactions between immune and endocrine system (Erasmus University Rotterdam 2000). Her multidisciplinary research focusses on interactions between biomedical and psychosocial aspects of health problems, with a focus on persistent somatic symptoms. She is project leader of the online expert system Grip. This system provides an innovative personalised treatment for persistent somatic symptoms. She is the chair of the Dutch national network on persistent somatic symptoms (NALK) and Deputy President of the European Association of Psychosomatic Medicine (EAPM). Rosmalen is the projectleader of the Innovative Training Network Encompassing Training in functional Disorders across Europe (ETUDE).
Sven Bølte, professor/psychologist
Autism and the learning environment
Professor of child and adolescent psychiatric science at the Department of Women’s and Children’s Health, Karolinska Institutet (KI), and senior clinical psychologist at the Division of Child and Adolescent Psychiatry, Center for Psychiatry Research, Region Stockholm, Sweden. He is director of the KI Center of Neurodevelopmental Disorders (“KIND”), editor of AUTISM, editor in chief of the Scandinavian Journal of Child and Adolescent Psychology and Psychiatry, and associate editor of Child and Adolescent Psychiatry and Mental Health. He is founder of the Scientific Society Autism Spectrum (www.wgas.org) and international ADOS and ADI-R trainer. For his work, he has received several recognitions, such as the ”Life Watch Nordiska Priset”, ”Årets Ljus” (Society Attention), Psynk award GNET” (Sweden’s Municipalities & Regions), Autism CRC (Australia) Achievement in Autism Research and ”Fellow of the International Society for Autism Research” (INSAR). Among his commissions of trust are appointments at the Swedish Research Council, the European Network of Hyperkinetic Disorders, the National Society Attention scientific board, the Swedish Autism and Asperger Society, the Swedish Psychiatry Foundation, Swedish National Board of Institutional Care, and the National Agency for Special Needs Education and Schools. Professor Bölte has published more than 400 original articles, reviews, book chapters, assessment and intervention tools in the field of autism spectrum, ADHD, and other neurodevelopmental conditions, and has been cited more than 25,000 times (H-index 75).
Twitter: @bolte_sven - Homepage: https://medarbetare.ki.se/people/sven-bolte
